医学
维生素D与神经学
维生素D缺乏
无症状的
人口
儿科
生理学
内科学
环境卫生
作者
US Preventive Services Task Force,Alex H. Krist,Karina W. Davidson,Carol M. Mangione,Michael D. Cabana,Aaron B. Caughey,Esa M. Davis,Katrina E Donahue,Chyke A. Doubeni,John W. Epling,Martha Kubik,Li Li,Gbenga Ogedegbe,Douglas K Owens,Lori Pbert,Michael Silverstein,James Stevermer,Chien‐Wen Tseng,John B. Wong
出处
期刊:JAMA
[American Medical Association]
日期:2021-04-13
卷期号:325 (14): 1436-1436
被引量:115
标识
DOI:10.1001/jama.2021.3069
摘要
Importance: Vitamin D is a fat-soluble vitamin that performs an important role in calcium homeostasis and bone metabolism and also affects many other cellular regulatory functions outside the skeletal system. Vitamin D requirements may vary by individual; thus, no one serum vitamin D level cutpoint defines deficiency, and no consensus exists regarding the precise serum levels of vitamin D that represent optimal health or sufficiency. Objective: To update its 2014 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review on screening for vitamin D deficiency, including the benefits and harms of screening and early treatment. Population: Community-dwelling, nonpregnant adults who have no signs or symptoms of vitamin D deficiency or conditions for which vitamin D treatment is recommended. Evidence Assessment: The USPSTF concludes that the overall evidence on the benefits of screening for vitamin D deficiency is lacking. Therefore, the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults cannot be determined. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults. (I statement).
科研通智能强力驱动
Strongly Powered by AbleSci AI